Reduction in Short-term Outpatient Consultations After a Campaign With Measles Vaccine in Children Aged 9-59 Months: Substudy Within a Cluster-Randomized Trial.
Child Mortality
Child, Preschool
Female
Guinea-Bissau
Hospitalization
/ statistics & numerical data
Humans
Immunization Programs
/ methods
Infant
Infant Mortality
Male
Measles
/ mortality
Measles Vaccine
/ adverse effects
Outpatients
Referral and Consultation
/ statistics & numerical data
Risk Factors
Vaccination
adverse events
beneficial nonspecific-effects
campaign
children
measles vaccine
Journal
Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049
Informations de publication
Date de publication:
10 Nov 2020
10 Nov 2020
Historique:
received:
04
05
2020
accepted:
14
07
2020
pubmed:
9
9
2020
medline:
14
5
2021
entrez:
8
9
2020
Statut:
ppublish
Résumé
We assessed a measles vaccination campaign's potential short-term adverse events. In a cluster-randomized trial assessing a measles vaccination campaign's effect on all-cause mortality and hospital admission among children aged 9-59 months in Guinea-Bissau, children received a measles vaccination (intervention) or a health check-up (control). One month to 2 months later, we visited a subgroup of children to ask mothers/guardians about outpatient consultations since enrollment. In log-binomial models, we estimated the relative risk (RR) of nonaccidental outpatient consultations. Among 8319 children (4437 intervention/3882 control), 652 nonaccidental outpatient consultations occurred (322 intervention/330 control). The measles vaccination campaign tended to reduce nonaccidental outpatient consultations by 16% (RR, 0.84 [95% confidence interval {CI}, .65-1.11]), especially if caused by respiratory symptoms (RR, 0.68 [95% CI, .42-1.11]). The reduction tended to be larger in children who prior to trial enrollment had a pentavalent vaccination (diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b) as the most recent vaccination (RR, 0.61 [95% CI, .42-.89]) than in children who prior to trial enrollment had a routine measles vaccination as the most recent vaccination (RR, 0.93 [95% CI, .68-1.26]) (P = .04 for interaction). In the short term, a measles vaccination campaign seems not to increase nonaccidental outpatient consultations but may reduce them. NCT03460002.
Sections du résumé
BACKGROUND
BACKGROUND
We assessed a measles vaccination campaign's potential short-term adverse events.
METHODS
METHODS
In a cluster-randomized trial assessing a measles vaccination campaign's effect on all-cause mortality and hospital admission among children aged 9-59 months in Guinea-Bissau, children received a measles vaccination (intervention) or a health check-up (control). One month to 2 months later, we visited a subgroup of children to ask mothers/guardians about outpatient consultations since enrollment. In log-binomial models, we estimated the relative risk (RR) of nonaccidental outpatient consultations.
RESULTS
RESULTS
Among 8319 children (4437 intervention/3882 control), 652 nonaccidental outpatient consultations occurred (322 intervention/330 control). The measles vaccination campaign tended to reduce nonaccidental outpatient consultations by 16% (RR, 0.84 [95% confidence interval {CI}, .65-1.11]), especially if caused by respiratory symptoms (RR, 0.68 [95% CI, .42-1.11]). The reduction tended to be larger in children who prior to trial enrollment had a pentavalent vaccination (diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b) as the most recent vaccination (RR, 0.61 [95% CI, .42-.89]) than in children who prior to trial enrollment had a routine measles vaccination as the most recent vaccination (RR, 0.93 [95% CI, .68-1.26]) (P = .04 for interaction).
CONCLUSIONS
CONCLUSIONS
In the short term, a measles vaccination campaign seems not to increase nonaccidental outpatient consultations but may reduce them.
CLINICAL TRIALS REGISTRATION
BACKGROUND
NCT03460002.
Identifiants
pubmed: 32897359
pii: 5902783
doi: 10.1093/jpids/piaa091
doi:
Substances chimiques
Measles Vaccine
0
Banques de données
ClinicalTrials.gov
['NCT03460002']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
535-543Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.